AIDS in Mexico: trends and projections

Bulletin of the Pan American Health Organization
|January 1, 1989
PubMed

Insights

Mexico reported its first acquired immune deficiency syndrome (AIDS) case in 1981. By mid-1988, over 1,500 cases were documented, with rapid incidence doubling, primarily through sexual transmission.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • The first reported case of acquired immune deficiency syndrome (AIDS) in Mexico was in 1981.
  • By mid-1988, 1,502 AIDS cases were reported, with incidence doubling every 7.7 months.

Purpose of the Study:

  • To analyze the transmission patterns and epidemiological trends of AIDS in Mexico.
  • To project future AIDS case numbers based on observed incidence rates.

Main Methods:

  • Analysis of reported AIDS cases in Mexico from 1981 to mid-1988.
  • Calculation of incidence doubling times and projection modeling.

Main Results:

  • In adults, 87.6% of AIDS cases were sexually transmitted, 10.8% from contaminated blood, and 0.3% from intravenous drug abuse.
  • In pediatric cases (56 reported), 67.9% were due to contaminated blood, 19.6% perinatal, and 5.4% sexual contact.
  • The disease is spreading from urban to rural areas and faster among heterosexuals.

Conclusions:

  • AIDS in Mexico shows a significant and growing burden, with distinct transmission routes in adults and children.
  • Projections indicate a substantial increase in cumulative AIDS cases, necessitating urgent public health interventions.
  • The observed spread patterns highlight the need for targeted prevention strategies, particularly concerning sexual transmission and geographic expansion.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...